Becker M A, Seegmiller J E
Arthritis Rheum. 1975 Nov-Dec;18(6 Suppl):687-94. doi: 10.1002/art.1780180708.
Work is continuing in the attempt to increase knowledge of the regulation of the rate of purine synthesis in man by means of an analysis of biochemical alterations leading to purine overproduction among patients with gout. The authors are now assessing the frequency of kinetic mutations in enzymes whose alterations already have been associated with increased purine synthesis. Efforts in this regard have been rewarded by the identification of a new form of alteration leading to partial deficiency of HGPRT and a kinetic variant of PRPP synthetase with increased affinity for ribose-5-phosphate. In order to identify new forms of enzyme abnormalities associated with excessive purine synthesis, the value of a proposed classification scheme requiring measurement of PRPP and ribose-5-phosphate concentration and generation is being assessed in cultured fibroblasts. It is hoped that the results of these measurements will lead to the identification of additional kinetic variants of presently known enzyme abnormalities and will help to identify new classes of mutants in the regulation of human purine metabolism. The excessive purine synthesis that underlies the hyperuricemia of a substantial number of patients with gouty arthritis reflects alterations in the normal mechanism regulating the rate of purine nucleotide synthesis. The study of such purine "overproducers" has provided insight into the nature of this regulatory mechanism and has underscored the diversity of specific genetic and biochemical aberrations affecting it. Despite these advances, however, less than 10% of all patients with gout and excessive purine production can presently be accounted for by known enzyme abnormalities (1). Recognition that current knowledge of the regulation of the rate of purine nucleotide synthesis in man is incomplete has provided the authors impetus leading to the studies described here, which are preceded by a brief review of background.
通过分析痛风患者中导致嘌呤产生过多的生化改变,人们仍在继续努力,试图增加对人体嘌呤合成速率调节的认识。作者目前正在评估那些改变已与嘌呤合成增加相关的酶的动力学突变频率。在这方面的努力已得到回报,发现了一种导致次黄嘌呤 - 鸟嘌呤磷酸核糖转移酶(HGPRT)部分缺乏的新改变形式,以及一种对5 - 磷酸核糖亲和力增加的磷酸核糖焦磷酸(PRPP)合成酶的动力学变体。为了识别与嘌呤合成过多相关的新的酶异常形式,正在培养的成纤维细胞中评估一种提议的分类方案的价值,该方案需要测量PRPP和5 - 磷酸核糖的浓度及生成情况。希望这些测量结果将有助于识别目前已知酶异常的其他动力学变体,并有助于识别人类嘌呤代谢调节中的新突变类别。大量痛风性关节炎患者高尿酸血症所基于的嘌呤合成过多反映了调节嘌呤核苷酸合成速率的正常机制的改变。对这些嘌呤“过度产生者”的研究为这种调节机制的本质提供了见解,并强调了影响它的特定遗传和生化异常的多样性。然而,尽管有这些进展,目前已知的酶异常仅能解释不到10%的痛风和嘌呤产生过多的患者(1)。认识到目前对人体嘌呤核苷酸合成速率调节的认识不完整,促使作者开展了此处所述的研究,在此之前先对背景进行了简要回顾。